23 Business Park Drive
Branford, CT 06405
Gary Mathias – email@example.com
Founded in 2011 by ex-Pfizer R&D executives and healthcare investors, Thetis Pharmaceuticals LLC is a biopharmaceutical company developing novel small molecule drugs for the treatment of Inflammatory Bowel Disease (IBD). Our proprietary HEALER™ technology unlocks the robust pharmacology of endogenous fatty acids to create non-immunosuppressive therapies based on a unique paradigm of resolving inflammation. In contrast to existing IBD therapies that work by blocking or inhibiting key steps in the inflammatory cascade, Thetis agents offer a fundamentally new pro-resolution approach to IBD treatment based on promoting tissue repair and healing without suppressing normal immunological function.